GirardR.M., LamarcheJ., BaillotR.. Carcinoma of the colon associated with pregnancy: report of a case.Dis Colon Rectum.1981; 24: 473–475.
2.
CappellM.S.. Colon cancer during pregnancy: the gastroenterologist's perspective.Gastroenterol Clin North Am.1998; 27: 225–256.
3.
BernsteinM.A., MadoffR.D., CaushajP.F.. Colon and rectal cancer in pregnancy.Dis Colon Rectum.1993; 36: 172–178.
4.
NesbittJ.C., MoiseK.J., SawyersJ.L.. Colorectal carcinoma in pregnancy.Arch Surg.1985; 120: 636–640.
5.
ParkerS.L., TongT., BoldenS.. Cancer statistics, 1997.CA Cancer J Clin.1997: 47: 5–27. Erratum in: CA Cancer J Clin. 1997; 47: 68.
6.
WalshC., FazioV.W.. Cancer of the colon, rectum, and anus during pregnancy: the surgeon's perspective.Gastroenterol Clin North Am.1998: 27; 257–267.
7.
DollD.C., RingenbergQ.S., YarbroJ.W.. Management of cancer during pregnancy.Arch Intern Med.1988: 148; 2058–2064.
8.
WoodsJ.B., MartinJ.N.Jr, IngramF.H.. Pregnancy complicated by carcinoma of the colon above the rectum.Am J Perinatol.1992: 9; 102–110.
9.
IsbisterW.H., FraserJ.. Large-bowel cancer in the young: a national survival study.Dis Colon Rectum.1990: 33; 363–366.
10.
FrancavillaA., Di LeoA., PolimenoL.. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding non cancerous colonic tissue.Gastroenterology.1987: 93: 1301–1306.
11.
HendrickseC.W., JonesC.E., DonovanI.A.. Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines.Br J Surg.1993: 80: 636–640.
12.
XuX., ThomasM.L.. Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro.Mol Cell Endocrinol.1994: 105: 197–201.
13.
SlatteryM.L., SamowitzW.S., HoldenJ.A.. Estrogen and progesterone receptors in colon tumors.Am J Clin Pathol.2000: 113: 364–368.
14.
KorenagaD., OritaH., MaekawaS.. Relationship between hormone receptor levels and cell-kinetics in human colorectal cancer.Hepatogastroenterology.1997: 44: 78–83.
15.
GeelhoedG.W., AlfordC., LippmanM.E.. Biologic implications of steroid hormone receptors in cancers of the colon.South Med J.1985: 78: 252–254.
MajerusP.W.. Prostaglandins: critical roles in pregnancy and colon cancer.Curr Biol.1998: 8: R87–R89.
18.
WilliamsC.S., SmalleyW., DuBoisR.N.. Aspirin use and potential mechanisms for colorectal cancer prevention.J Clin Invest.1997: 100: 1325–1329.
19.
GiovannucciE., RimmE.B., StampferM.J.. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals.Ann Intern Med.1994: 121: 241–246.
20.
BalthazerE.J., MegibowA.J., HulnickD.. Carcinoma of the colon: detection and preoperative staging by CT.AJR Am J Roentgenol.1988: 150: 301–306.
21.
CappellM.S.. Gastrointestinal endoscopy in high risk patients.Dig Dis.1996: 14: 228–244.
22.
MelmedA.D.. Anesthesia principles and techniques in pregnancy. In: CherrS.T., MerkatzI.R., eds. Complications of Pregnancy: Medical, Surgical, Gynecologic, Psychosocial, and Perinatal.4th ed.Baltimore, Md: Williams and Wilkins;1991.
CappellM.S., ColonV.J., SidhomO.A.. A study of eight medical centers of the safety and clinical efficacy of esophagogastroduodenoscopy in 83 pregnant females with follow-up of fetal in 83 pregnant females with follow-up of fetal outcome and with comparison control groups.Am J Gastroenterol.1996: 91: 348–354.
25.
LamerzR., RuiderH.. Significance of CEA determinations in patients with cancer of the colon-rectum and the mammary gland in comparison to physiological states in connection with pregnancy.Bull Cancer.1976: 63: 575–586.
BrentR.L.. The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks.Semin Oncol.1989: 16: 347–368.
29.
LeesW.R.. Ultrasound of liver and spleen. In: SuttonD., IsherwoodI., ForbesW., eds. A Textbook of Radiology and Imaging.5th ed.Edinburgh, NY: Churchill Livingstone;1993.
30.
NiesC., LeppekR., SitterH.. Prospective evaluation of different diagnostic techniques for the detection of liver metastases at time of primary resection of colorectal carcinoma.Eur J Surg.1996: 162: 811–816.
31.
SeidmanD.S., HeymanZ., Ben-AriG.Y.. Use of magnetic imaging in pregnancy to diagnose intussusception induced by colonic cancer.Obstet Gynecol.1992: 79: 822–823.
PitlukH., PotichaS.M.. Carcinoma of the colon and rectum in patients less than 40 years of age.Surg Gynecol Obstet.1983: 157: 335–337.
35.
RecaldeM., HolyokeE.D., EliasE.G.. Carcinoma of the colon, rectum and anal canal in young patients.Surg Gynecol Obstet.1974: 139: 909–913.
36.
MotwaniB.T., ShafirM., MerrickM.. Adenocarcinoma of the colon and rectum. In: HollandJ.F., FreiEIII, BastR.C.Jr,, eds. Cancer Medicine.4th ed.Baltimore, Md: Williams & Wilkins;1997.
37.
FleshmanJ.W., MyersonR.J.. Adjuvant radiation therapy for adenocarcinoma of the rectum.Surg Clin North Am.1997: 77: 15–25.
WeeksA.E., AbbruzzeseJ.L., LevinB.. Current status of chemotherapy for colorectal cancer.Drug Ther (NY).1989: 19: 36–55.
40.
GrageT.B., MossS.E.. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled, randomized trial.Surg Clin North Am.1981: 61: 1321–1329.
41.
HigginsG.A., LeeL.E., DwightR.W.. The case for adjuvant 5-fluorouracil in colorectal cancer.Cancer Clin Trials.1978: 1: 35.
42.
MacDonaldJ.S.. Adjuvant therapy for colon cancer.CA Cancer J Clin.1997: 47: 243–256.
43.
MoertelC.G., FlemingT.R., MacDonaldJ.S.. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.Ann Intern Med.1995: 122: 321–326.
44.
ChabnerB.A., AllegraC.J., CurtG.A.. Antineoplastic agents. In: HardmanJ.G., LimbirdL.E., MolinoffP.B., eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics.9th ed.New York, NY: McGraw-Hill, Health Professions Division;1996.
45.
ShueyD.L., BuckalewA.R., WilkeT.S.. Early events following maternal exposure to 5-fluorouracil lead to dysmorphology in cultured embryonic tissues.Teratology.1994: 50: 379–386.
46.
SommersG.M., KaoM.S.. Using chemotherapeutic agents during pregnancy.Contemp Obstet Gynecol.1987: 30: 45–48.
47.
AvilesA., Diaz-MaqueoJ.C., TalaveraA.. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.Am J Hematol.1991: 36: 243–248.
48.
LaurieJ.A., MoertelC.G., FlemingT.R.. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.J Clin Oncol.1989: 7: 1447–1456.
49.
MoertelC.G., FlemingT.R., MacDonaldJ.S.. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.N Engl J Med.1990: 322: 352–358.
50.
LiptonL.R., JohnsonV., CummingsC.. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.J Clin Oncol.2004; 22: 4934–4943.
51.
UmarA., BolandC.R., TerdimanJ.P.. Revised Bethesda guidelines for hereditary non-polyposis colorectal cancer and microsatellite instability.J Natl Cancer Inst.2004; 96: 261–268.
52.
ChanY.M., NgaiS.W., LaoT.T.. Colon cancer in pregnancy: a case report.J Reprod Med.1999: 44: 733–736.